These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. HSP90 and the chaperoning of cancer. Whitesell L; Lindquist SL Nat Rev Cancer; 2005 Oct; 5(10):761-72. PubMed ID: 16175177 [TBL] [Abstract][Full Text] [Related]
28. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways. Gazitt Y; Kolaparthi V; Moncada K; Thomas C; Freeman J Int J Oncol; 2009 Feb; 34(2):551-61. PubMed ID: 19148492 [TBL] [Abstract][Full Text] [Related]
29. Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells. Yang TT; Hsu CT; Kuo YM Mech Ageing Dev; 2009 Sep; 130(9):592-601. PubMed ID: 19622370 [TBL] [Abstract][Full Text] [Related]
30. Concerted actions of multiple transcription elements confer differential transactivation of HSP90 isoforms in geldanamycin-treated 9L rat gliosarcoma cells. Chao CC; Sun FC; Wang CH; Lo CW; Chang YS; Chang KC; Chang MD; Lai YK J Cell Biochem; 2008 Jul; 104(4):1286-96. PubMed ID: 18320580 [TBL] [Abstract][Full Text] [Related]
31. NMR backbone assignment of the N-terminal domain of human HSP90. Jacobs DM; Langer T; Elshorst B; Saxena K; Fiebig KM; Vogtherr M; Schwalbe H J Biomol NMR; 2006; 36 Suppl 1():52. PubMed ID: 16821127 [No Abstract] [Full Text] [Related]
32. Evaluation of prostate-specific antigen as a novel biomarker of Hsp90 inhibition. Oikonomopoulou K; Soosaipillai A; Diamandis EP Clin Biochem; 2009 Nov; 42(16-17):1705-12. PubMed ID: 19632215 [TBL] [Abstract][Full Text] [Related]
33. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Landriscina M; Amoroso MR; Piscazzi A; Esposito F Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270 [TBL] [Abstract][Full Text] [Related]
34. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. Kang BH; Plescia J; Song HY; Meli M; Colombo G; Beebe K; Scroggins B; Neckers L; Altieri DC J Clin Invest; 2009 Mar; 119(3):454-64. PubMed ID: 19229106 [TBL] [Abstract][Full Text] [Related]
35. Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation. Didelot C; Lanneau D; Brunet M; Bouchot A; Cartier J; Jacquel A; Ducoroy P; Cathelin S; Decologne N; Chiosis G; Dubrez-Daloz L; Solary E; Garrido C Cell Death Differ; 2008 May; 15(5):859-66. PubMed ID: 18239673 [TBL] [Abstract][Full Text] [Related]
36. Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment. Jayanthan A; Fowler J; Hawkins L; Lamers F; Teja B; Incoronato A; Anderson R; Narendran A J Exp Ther Oncol; 2008; 7(3):183-93. PubMed ID: 19066127 [TBL] [Abstract][Full Text] [Related]
37. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186 [TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 90 regulates development in Dictyostelium discoideum. Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841 [TBL] [Abstract][Full Text] [Related]
39. The mitochondrial UPR - protecting organelle protein homeostasis. Haynes CM; Ron D J Cell Sci; 2010 Nov; 123(Pt 22):3849-55. PubMed ID: 21048161 [TBL] [Abstract][Full Text] [Related]